Trial Profile

Study of Evaluating Quetiapine in Improving Sleep Quality of Schizophrenia.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Jun 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Quetiapine (Primary) ; Haloperidol
Indications Schizophrenia
Focus Pharmacodynamics

Most Recent Events

01 Sep 2010 Results were presented at the 23rd Annual Congress of the European College of Neuropsychopharmacology.
06 Jun 2010 Results have been presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
10 Apr 2008 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com